Repository logo
 

Cucurbitacin IIa: a novel class of anti-cancer drug inducing non-reversible actin aggregation and inhibiting survivin independent of JAK2/STAT3 phosphorylation

dc.contributor.authorBoykin, Christi
dc.contributor.authorZhang, G.
dc.contributor.authorChen, Yan-Hua
dc.contributor.authorZhang, R-W
dc.contributor.authorFan, X-E
dc.contributor.authorYang, W-M
dc.contributor.authorLu, Q.
dc.date.accessioned2016-05-24T18:40:32Z
dc.date.available2016-05-24T18:40:32Z
dc.date.issued2011-03
dc.identifier.citationBritish Journal of Cancer; 104:5 p. 781-789en_US
dc.identifier.doi10.1038/bjc.2011.10
dc.identifier.issn0007-0920
dc.identifier.pmidpmc3048206en_US
dc.identifier.urihttp://hdl.handle.net/10342/5298
dc.relation.urihttp://www.ncbi.nlm.nih.gov/pubmed/21304528en_US
dc.titleCucurbitacin IIa: a novel class of anti-cancer drug inducing non-reversible actin aggregation and inhibiting survivin independent of JAK2/STAT3 phosphorylationen_US
dc.typeArticleen_US
ecu.journal.issue5en_US
ecu.journal.nameBritish Journal of Canceren_US
ecu.journal.pages781-789en_US
ecu.journal.volume104en_US

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
bjc201110a.PMC3048206.pdf
Size:
757.01 KB
Format:
Adobe Portable Document Format